Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T16:10:40.063Z.
Calculation as of: 2026-10-06T16:10:40.063Z.
Quote observation: 2026-10-06T16:09:43.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ce14650c18fa49a41504767bbd6ec089d5034b69e4d808542ce8aeb5b63776d1
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Market Cap
$149.51M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$155.86M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$158.63M
EV/EBIT Ratio
N/A
TTM Avg
24.87x
3Y Avg
24.87x
5Y Avg
24.87x
Market Cap
$148.36M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ALX Oncology Holdings Inc. (ALXO) | $154.07M | N/A | N/A | N/A | N/A |
| Cardiol Therapeutics Inc. (CRDL)vs › | $152.74M | N/A | N/A | N/A | N/A |
| Anavex Life Sciences Corp. (AVXL)vs › | $151.52M | N/A | N/A | N/A | N/A |
| Codexis, Inc. (CDXS)vs › | $151.12M | N/A | N/A | N/A | N/A |
| Inogen, Inc. (INGN)vs › | $158.32M | N/A | 189.93x | 95.49x | 94.46x |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $149.51M | N/A | N/A | N/A | N/A |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $155.86M | N/A | N/A | N/A | N/A |
| Minerva Neurosciences, Inc. (NERV)vs › | $158.63M | N/A | 24.87x | 24.87x | 24.87x |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $148.36M | N/A | N/A | N/A | N/A |
| LifeMD, Inc. (LFMDP)vs › | $147.97M | N/A | 1490.94x | 1490.94x | 1490.94x |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
